 NEW YORK, Oct. 15, 2021 PRNewswire -- Pomerantz LLP is investigating claims on behalf of investors of Allogene Therapeutics, Inc. Allogene or the Company NASDAQ: ALLO. Such investors are advised to contact Robert S. 